The American Thoracic Society (ATS) International Conference is the home of pulmonary, critical care and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. This year, the society convened in Washington, DC, from May 19-24.
Charles River scientists were on hand to participate in the exciting discourse on the current state and challenges facing the pulmonary disease research community, presenting three posters at this event:
- A Comparison of Compounds with Claimed Anti-Fibrotic Activity in Novel Human Fibroblast and Epithelial Transition Assays Using IPF Derived Patient Material
- Respiratory Function and Quantitative Measurement of Fibrosis in a Rat Model of Bleomycin-Induced Lung Fibrosis
- Quantification of Differential Fibrotic Lesions by Image Analysis in the Mouse Bleomycin Model of Pulmonary Fibrosis